Humanigen Inc (HGENQ)

[DonDonDonDon]

@KnuckleSandwic8

“After the initial trial, we and Humanigen decided that ifabotuzumab is an ideal candidate to deliver cancer killing drug payloads to cancers, including brain cancer but also other cancers such as lung cancer, colon cancer and breast cancer. "https://t.co/rDR9iHKO9W$HGEN

— Knuckle Sandwich (@KnuckleSandwic8) June 20, 2022

“After the initial trial, we and Humanigen decided that ifabotuzumab is an ideal candidate to deliver cancer killing drug payloads to cancers, including brain cancer but also other cancers such as lung cancer, colon cancer and breast cancer. "

https://www.onjcri.org.au/uncategorized/clinical-trial-lighting-up-hope-for-brain-cancer-patients/